Company or ticker...

Relay Therapeutics

Relay uses structural biology and computation to design precision cancer medicines.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

RLAY

4.4B

399.1

n/a

142.51%

Key Facts

M. Cap

PS

PE

YTD

4.4B

399.1

n/a

142.51%

10MA

20MA

50MA

200MA

$RLAY